Feedback / Questions
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
https://www.globenewswire.com/news-release/2026/06/24/3316568/0/en/MoonLake-Immunotherapeutics-Announces-Pricing-of-Upsized-200-Million-Public-Offering.html
Jun 23, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next